These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7682466)
21. Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3. Burrows SR; Gardner J; Khanna R; Steward T; Moss DJ; Rodda S; Suhrbier A J Gen Virol; 1994 Sep; 75 ( Pt 9)():2489-93. PubMed ID: 7521394 [TBL] [Abstract][Full Text] [Related]
22. Measles virus hemagglutinin induces an Ld-restricted CD8+ cytotoxic T lymphocyte response to two specific epitopes. Beauverger P; Buckland R; Wild F Virology; 1994 Apr; 200(1):281-3. PubMed ID: 7510439 [TBL] [Abstract][Full Text] [Related]
23. Analysis of the antigenic profile of measles virus haemagglutinin in mice and humans using overlapping synthetic peptides. Obeid OE; Partidos CD; Steward MW Virus Res; 1994 Apr; 32(1):69-84. PubMed ID: 7518172 [TBL] [Abstract][Full Text] [Related]
24. Antiviral cytotoxic T lymphocyte induction and vaccination. Rouse BT; Norley S; Martin S Rev Infect Dis; 1988; 10(1):16-33. PubMed ID: 2451265 [TBL] [Abstract][Full Text] [Related]
25. T cell immunity to measles viral proteins in infants and adults after measles immunization. Gans HA; Yasukawa LL; Alderson A; Rinki M; Dehovitz R; Maldonado Y; Arvin AM Viral Immunol; 2004; 17(2):298-307. PubMed ID: 15279707 [TBL] [Abstract][Full Text] [Related]
26. Human leukocyte antigen class I- and class II-restricted cytotoxic T lymphocyte responses to measles antigens in immune adults. Jaye A; Magnusen AF; Whittle HC J Infect Dis; 1998 May; 177(5):1282-9. PubMed ID: 9593013 [TBL] [Abstract][Full Text] [Related]
28. Recognition of intracellular measles virus antigens by HLA class II restricted measles virus-specific cytotoxic T lymphocytes. Jacobson S; Sekaly RP; Bellini WJ; Johnson CL; McFarland HF; Long EO Ann N Y Acad Sci; 1988; 540():352-3. PubMed ID: 2905123 [No Abstract] [Full Text] [Related]
29. Measles virus antigens induce both type-specific and canine distemper virus cross-reactive cytotoxic T lymphocytes in mice: localization of a common Ld-restricted nucleoprotein epitope. Beauverger P; Buckland R; Wild TF J Gen Virol; 1993 Nov; 74 ( Pt 11)():2357-63. PubMed ID: 7504072 [TBL] [Abstract][Full Text] [Related]
30. [The specific activity and immunological safety of the intranasal method of revaccination with a live measles vaccine made from the Leningrad-16 strain]. Iuminova NV; Krasnova VP; Liashenko VA; Vedunova SL Vopr Virusol; 1993; 38(3):111-3. PubMed ID: 7521099 [TBL] [Abstract][Full Text] [Related]
31. High-level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: induction of an MHC-1-restricted CTL response and protection in a murine model. Fooks AR; Schadeck E; Liebert UG; Dowsett AB; Rima BK; Steward M; Stephenson JR; Wilkinson GW Virology; 1995 Jul; 210(2):456-65. PubMed ID: 7618280 [TBL] [Abstract][Full Text] [Related]
32. Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus. Brandler S; Lucas-Hourani M; Moris A; Frenkiel MP; Combredet C; Février M; Bedouelle H; Schwartz O; Desprès P; Tangy F PLoS Negl Trop Dis; 2007 Dec; 1(3):e96. PubMed ID: 18160988 [TBL] [Abstract][Full Text] [Related]
33. Analysis of antibody response to the measles virus using synthetic peptides of the fusion protein. Evidence of non-random pairing of T and B cell epitopes. Muller CP; Handtmann D; Brons NH; Weinmann M; Wiesmüller KH; Spahn G; Wiesneth M; Schneider F; Jung G Virus Res; 1993 Dec; 30(3):271-80. PubMed ID: 8109160 [TBL] [Abstract][Full Text] [Related]
34. A Recombinant Measles Vaccine with Enhanced Resistance to Passive Immunity. Julik E; Reyes-Del Valle J Viruses; 2017 Sep; 9(10):. PubMed ID: 28934110 [TBL] [Abstract][Full Text] [Related]
36. Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination. Ward BJ; Boulianne N; Ratnam S; Guiot MC; Couillard M; De Serres G J Infect Dis; 1995 Dec; 172(6):1591-5. PubMed ID: 7594723 [TBL] [Abstract][Full Text] [Related]
37. The potential of immunization with synthetic peptides to overcome the immunosuppressive effect of maternal anti-measles virus antibodies in young mice. Obeid OE; Steward MW Immunology; 1994 May; 82(1):16-21. PubMed ID: 8045592 [TBL] [Abstract][Full Text] [Related]
39. [Measles vaccination: study of humoral immunity in children vaccinated in the Tunis region]. Arrouji A; Mirchamsy H; Marnissi A Arch Inst Pasteur Tunis; 1982 Mar; 59(1):173-80. PubMed ID: 7181563 [No Abstract] [Full Text] [Related]
40. [Seroconversion with measles vaccine in children 8-18 months old]. Díaz-Ortega JL; Zárate-Aquino ML; Valdespino-Gómez JL; Cardenas-Ayala VM; Ruíz-Matus C Bol Med Hosp Infant Mex; 1986 Sep; 43(9):526-31. PubMed ID: 3790224 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]